BMC Neurol

1. YOSHIMURA S, Yamaguchi S, Nakamura H, Hirayama K, et al
   Diffuse sulcal hyperintensity on MRI as a radiological correlate of transient neurological deficits in chronic subdural hematoma.
   BMC Neurol. 2026 Apr 23. doi: 10.1186/s12883-026-04913.
   

   >> Share

   
   

   
   Br J Neurosurg

2. HARRIS L, Murphy S, Mukerji N
   Wellness in neurosurgery.
   Br J Neurosurg. 2026 Apr 20:1-3. doi: 10.1080/02688697.2026.2661535.
   

   >> Share

   
   

   
   Exp Neurol

3. KIM J, Lee J, Kwon J, Kwon M, et al
   Imbalance of nociceptive homeostasis drives spinal cord injury pain.
   Exp Neurol. 2026 Apr 16:115786. doi: 10.1016/j.expneurol.2026.115786.
   

   >> Share

   
   

   
   Int J Radiat Oncol Biol Phys

4. GLICKSMAN RM, Winter J, McPartlin A, Santiago AT, et al
   Stereotactic Body Radiation Therapy for Renal Tumors: A Prospective Phase 2 Clinical Trial.
   Int J Radiat Oncol Biol Phys. 2026;125:154-163.
   

   >> Share

   
   
5. CEDOZ E, Levy A, Martel-Lafay I, Bondiau PY, et al
   Stereotactic Versus Standard Tumor Irradiation in Unresectable Locally Advanced Non-small Cell Lung Cancer With Durvalumab Maintenance: A Multicenter Study With Propensity Score Matching.
   Int J Radiat Oncol Biol Phys. 2026;125:112-122.
   

   >> Share

   
   
6. ALI M, Correa RJM, Pryor D, Higgs B, et al
   Efficacy of SABR in Uncommon Subtypes of Primary Kidney Cancer: An Analysis From the International Radiosurgery Oncology Consortium of the Kidney.
   Int J Radiat Oncol Biol Phys. 2026;125:146-153.
   

   >> Share

   
   
7. MAURY P, Sayous Y, Marnaoui R, Loiseau C, et al
   Stereotactic Ablative Radiotherapy (SABR) Quality and Survival of Patients with Head and Neck Cancer: a post-hoc analysis of the GORTEC 2014-04 "OMET" Randomised Phase 2 Trial.
   Int J Radiat Oncol Biol Phys. 2025 Jul 24:S0360-3016(25)06019.
   

   >> Share

   
   
8. SPINDLER NJ, Felter MVO, Hansen O, Nielsen TB, et al
   Stereotactic Ablative Radiation Therapy of Bone Metastases in an Oligometastatic Setting: One-Year Follow-Up of the BONY-M Phase 2 Trial.
   Int J Radiat Oncol Biol Phys. 2026;125:320-329.
   

   >> Share

   
   
9. VARGAS C, Carrello J, Bressel M, Sidhom M, et al
   SABR Versus Radiofrequency Ablation and Cryoablation for Primary Renal Cell Carcinoma: An Economic Evaluation of the FASTRACK II Trial.
   Int J Radiat Oncol Biol Phys. 2026;125:173-184.
   

   >> Share

   
   
10. COURTNEY PT, Dong H, Lao Y, Pham J, et al
    Dosimetric Comparison of MRI-Guided Versus Reduced Margin CT-Guided Stereotactic Body Radiotherapy for Localized Prostate Cancer: Post-Hoc Analysis of a Phase III Trial.
    Int J Radiat Oncol Biol Phys. 2025 Jun 5:S0360-3016(25)00553.
    

    >> Share

    
    
11. KATIPALLY RR, Rajeev-Kumar G, Solanki AA, Arif F, et al
    A Prospective Study of Stereotactic Body Radiation Therapy in Oligometastatic Renal Cell Carcinoma.
    Int J Radiat Oncol Biol Phys. 2026;125:164-170.
    

    >> Share

    
    
12. AHMED KA, Quick AM, Chon HS, Chern JY, et al
    Atezolizumab and Stereotactic Body Radiation in Metastatic, Recurrent, or Persistent Cervical Cancer: Results from a Phase II Multi-Institutional Study.
    Int J Radiat Oncol Biol Phys. 2025 May 14:S0360-3016(25)00446.
    

    >> Share

    
    
13. KOOYMAN A, Chang JS, Liu M, Jiang W, et al
    Evaluating Toxicity and Interaction Outcomes of Systemic Therapy and Stereotactic Ablative Radiation Therapy for Oligometastatic Disease: A Secondary Analysis of the Phase 2 SABR-5 Trial.
    Int J Radiat Oncol Biol Phys. 2026;125:338-347.
    

    >> Share

    
    
14. SINGH M, Katdare A, Ghosh S, Choudhury S, et al
    PSMA-PET-Guided Intraprostatic Boost in Prostate SBRT (PROBE): A Phase 2 Trial.
    Int J Radiat Oncol Biol Phys. 2026;125:203-213.
    

    >> Share

    
    
15. PATEL P, Dreibe S, Attard G, Cole A, et al
    Stereotactic body radiotherapy for oligoprogressive disease in androgen suppressed prostate cancer: Primary endpoint analysis of the TRAP trial.
    Int J Radiat Oncol Biol Phys. 2025 Mar 9:S0360-3016(25)00225.
    

    >> Share

    
    
16. BAKER S, Leclerc C, Atmanspacher-Wirth H, Zhao Y, et al
    The Impact of Ultracentral Tumor Location on Outcomes in Patients with Pulmonary Oligometastases: A Secondary Analysis of the Single-Arm Phase 2 SABR-5 Trial.
    Int J Radiat Oncol Biol Phys. 2026;125:102-111.
    

    >> Share

    
    
17. TWARD J, Lloyd S, Johnson S, Dechet C, et al
    A Phase 2 Trial of Radium(223) and Stereotactic Ablative Radiotherapy in Hormone-Naive Men with Oligometastatic Prostate Cancer to Bone: The RadSABR study.
    Int J Radiat Oncol Biol Phys. 2025 Feb 6:S0360-3016(25)00095.
    

    >> Share

    
    
18. RATNAKUMARAN R, Sasitharan A, Khan A, Mayet H, et al
    Dosimetric Comparison of CyberKnife and Conventional Linac Prostate Stereotactic Body Radiation Therapy Plans: Analysis of the PACE-B Study.
    Int J Radiat Oncol Biol Phys. 2026;125:250-256.
    

    >> Share

    
    
19. JACOMINA LE, Sogono PG, Agas RAF, Cereno REP, et al
    Building Comprehensive Stereotactic Body Radiation Therapy Programs in a Limited-Resource Setting: Experience From the Philippines.
    Int J Radiat Oncol Biol Phys. 2026;125:26-32.
    

    >> Share

    
    
20. VARGAS CE, Voss MM, Dodoo C, Wong W, et al
    Outcomes of a Phase II Interventional Clinical Trial of Prostate Bed Stereotactic Body Radiation Therapy for Prostate Cancer with High-Risk Features Following Radical Prostatectomy.
    Int J Radiat Oncol Biol Phys. 2026 Feb 17:S0360-3016(26)00328.
    

    >> Share

    
    
21. BERGOM C, Knutson NC, Jiang S, Javaheri A, et al
    STAR Power: Noninvasive Radiation Therapy for Ventricular Tachycardia Enters a New Era.
    Int J Radiat Oncol Biol Phys. 2026;125:21-25.
    

    >> Share

    
    
22. SCHMITT LG, Dohopolski M, de Vis J, Mostardeiro TR, et al
    Adaptive MRI-Guided Reirradiation for High-Risk Recurrent Grade 4 Gliomas: Early Clinical Outcomes and Volumetric Response.
    Int J Radiat Oncol Biol Phys. 2026 Feb 7:S0360-3016(26)00329.
    

    >> Share

    
    
23. HANNA TP, Palma DA, Booth CM, Sanford NN, et al
    Generating the Evidence to Support Stereotactic Radiation Therapy Evolution: Challenges and a Roadmap for Progress.
    Int J Radiat Oncol Biol Phys. 2026;125:2-10.
    

    >> Share

    
    
24. CHETTY IJ, Zhong H
    Deformable Dose Mapping and Accumulation Techniques for Stereotactic Body Radiation Therapy (SBRT) of Lung Cancers.
    Int J Radiat Oncol Biol Phys. 2026;125:86-101.
    

    >> Share

    
    
25. LECLERC C, Baker S, Jiang W, Mou B, et al
    Treatment With Stereotactic Ablative Radiation Therapy for Patients With up to 5 Oligometastatic Cancer Lesions: Long-Term Outcomes of the Nonrandomized Population-based Phase 2 SABR-5 Clinical Trial.
    Int J Radiat Oncol Biol Phys. 2026;125:330-337.
    

    >> Share

    
    
26. DHAR A, Siva S, Tan VS, Mahadevan A, et al
    International Radiosurgery Oncology Consortium of the Kidney (IROCK) Contouring Guidelines for Renal Cell Carcinoma Treated With Stereotactic Ablative Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2026;125:136-145.
    

    >> Share

    
    
27. KEALL PJ, Booth J, Eade T, Hewson EA, et al
    The KIM real-time prostate cancer IGRT technology journey: From clinical trials to your clinic.
    Int J Radiat Oncol Biol Phys. 2026 Jan 18:S0360-3016(26)00083.
    

    >> Share

    
    
28. HELOU J, Glicksman R, Bezjak A, Raman S, et al
    Health-Related Quality of Life After SBRT for Oligoprogressive Disease: Results From a Phase II Prospective Trial.
    Int J Radiat Oncol Biol Phys. 2026;125:348-357.
    

    >> Share

    
    
29. CORREA RJM, Ali M, Tan VS, Siva S, et al
    Renal SABR: Implementation of A New Standard of Care.
    Int J Radiat Oncol Biol Phys. 2026;125:123-135.
    

    >> Share

    
    
30. YASAR B, Suh YE, Chapman E, Nicholls L, et al
    2-year outcomes of the SPARC phase II trial: Simultaneous focal boost with stereotactic radiotherapy for localised intermediate to high-risk prostate cancer.
    Int J Radiat Oncol Biol Phys. 2026 Jan 11:S0360-3016(26)00019.
    

    >> Share

    
    
31. SO J, Droznin A, Tiwari P, Chen YH, et al
    Stereotactic Body Radiation Therapy With Pembrolizumab in PD-1 Inhibitor Refractory, Recurrent or Metastatic, Head and Neck Squamous Cell Carcinoma: A Phase 2 Trial.
    Int J Radiat Oncol Biol Phys. 2026 Jan 9:S0360-3016(26)00004.
    

    >> Share

    
    
32. FAKIR H, Redler G, Bauman GS, Caudell JJ, et al
    Practical Aspects of Delivering Radiation for Polymetastatic Disease.
    Int J Radiat Oncol Biol Phys. 2026;125:306-319.
    

    >> Share

    
    
33. DASSEN MG, Tree AC, Wiersema L, Neijndorff B, et al
    Primary endpoint analysis of the phase II DESTINATION-MRL trial for patients with intermediate-risk prostate cancer.
    Int J Radiat Oncol Biol Phys. 2025 Nov 26:S0360-3016(25)06502.
    

    >> Share

    
    

    
    Neurosurgery

34. ST BRICE K, Cruickshank RR, Calderon C, Toledo MM, et al
    Female Pioneers in Neurosurgery in the Caribbean.
    Neurosurgery. 2026 Apr 21. doi: 10.1227/neu.0000000000004037.
    

    >> Share

    
    
35. SURYADEVARA CM, Salcedo-Sifuentes JE, Little AS, Yuen KCJ, et al
    Standardized Perioperative Protocols Are Associated With Reduced Length of Stay and Readmission in Cushing Disease: Results From the Multicenter RAPID Study.
    Neurosurgery. 2026 Apr 21. doi: 10.1227/neu.0000000000003992.
    

    >> Share

    
    
36. JANG HJ, Kim DK, Moon BJ, Kim KH, et al
    Reduction of Spinal Cord Cross-Sectional Area Is Associated With Myelopathy in Severe Cervical Ossification of the Posterior Longitudinal Ligaments.
    Neurosurgery. 2026 Apr 21. doi: 10.1227/neu.0000000000004059.
    

    >> Share

    
    
37. ABOU-AL-SHAAR H, Wrigley R, Passeri T, Tang A, et al
    Pattern of Intracranial Meningiomas Associated With Prolonged DMPA Use: Systematic Review of Synthetic Progestins and Case Series of DMPA-Associated Intracranial Meningiomas.
    Neurosurgery. 2026 Apr 21. doi: 10.1227/neu.0000000000004031.
    

    >> Share

    
    
38. MATSUKAWA H, Fujita M, Kuramoto Y, Kuwahara S, et al
    Pre-existing Gut Microbiome Dysbiosis Exacerbates Neuroinflammation and Vasospasm After Subarachnoid Hemorrhage in Mice.
    Neurosurgery. 2026 Apr 21. doi: 10.1227/neu.0000000000004035.
    

    >> Share

    
    
39. BECERRIL-GAITAN A, Liu C, Ding D, Southerland AM, et al
    Associated Factors and Outcomes of Patients With Intracerebral Hemorrhage After Permanent Cerebrospinal Fluid Shunt Placement.
    Neurosurgery. 2026 Apr 22. doi: 10.1227/neu.0000000000004056.
    

    >> Share

    
    
40. NICHOLS CS, Lesha E, Konakalla P, Parikh KA, et al
    Inappropriate Use of Anticoagulants and Antiplatelets in Intracranial Hemorrhage Patients: A Retrospective Study From a Tertiary Referral Level 1 Trauma Center.
    Neurosurgery. 2026 Apr 22. doi: 10.1227/neu.0000000000004052.
    

    >> Share

    
    
41. STUART MJ, Steinberg GK
    Prognostic Nuances in the Microsurgical Resection of Arteriovenous Malformations in Areas of Critical Brain Function: A 25-Year Retrospective Cohort Study.
    Neurosurgery. 2026 Apr 22. doi: 10.1227/neu.0000000000004066.
    

    >> Share

    
    
42. REYES JS, Bouras A, Hadjipanayis CG, Lunsford LD, et al
    Long-Term Outcomes After Gamma Knife Radiosurgery for Craniopharyngioma: A Single-Center Retrospective Study.
    Neurosurgery. 2026 Apr 22. doi: 10.1227/neu.0000000000004081.
    

    >> Share

    
    
43. SCARRAMAL JPL, Fernandes JVA, Cardoso LJC, Cabral Junior SG, et al
    Comparison of Long and Short Stent Retrievers in Mechanical Thrombectomy for Acute Ischemic Stroke Due to Large Vessel Occlusion: A Systematic Review and Meta-Analysis.
    Neurosurgery. 2026 Apr 22. doi: 10.1227/neu.0000000000004034.
    

    >> Share

    
    
44. SARATHY D, Lucke-Wold B, Koch M
    Commentary: Identifying the Symptomatic Aneurysm in Patients With Multiple Intracranial Aneurysms.
    Neurosurgery. 2026 Apr 22. doi: 10.1227/neu.0000000000004067.
    

    >> Share

    
    
45. PERDOMO-PANTOJA A, Shafi M, Sarkar N, Rajkovic C, et al
    Enhancing Lumbar Spinal Fusion Using Hypoxia Preconditioned Culture-Expanded Adipose-Derived Mesenchymal Stem Cells: Evidence From a Rat Posterolateral Lumbar Spinal Fusion Model.
    Neurosurgery. 2026 Apr 22. doi: 10.1227/neu.0000000000004055.
    

    >> Share

    
    
46. CEPEDA S, Rizoudis A, Muller D, Kramer F, et al
    Development and External Validation of a Deep Learning Model to Predict Mortality in Aneurysmal Subarachnoid Hemorrhage Using Admission Computed Tomography.
    Neurosurgery. 2026 Apr 23. doi: 10.1227/neu.0000000000004038.
    

    >> Share

    
    
47. SCHNURMAN Z, Kondziolka D
    Risk-Weighted Impact: Reframing Risk Analyses for Medical Decisions.
    Neurosurgery. 2026 Apr 23. doi: 10.1227/neu.0000000000004053.
    

    >> Share

    
    
48. MESINA-ESTARRON I, Earl ER, Chambless LB, Gomes FC, et al
    Building Bridges: A Dual-Perspective Framework for Neurosurgical Research Mentorship.
    Neurosurgery. 2026 Apr 23. doi: 10.1227/neu.0000000000004051.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share